Intravenous Thrombolytic Therapy in Acute Stroke: Frequent Systemic Problems and Solutions
One of the most important reasons why the use of the intravenous (IV) tissue plasminogen activator (tPA), which is one of the key elements of acute ischemic stroke treatment, is not sufficiently widespread is the fact that many common questions have not been adequately answered. In this review, ques...
Main Authors: | Mehmet Akif Topçuoğlu, Ethem Murat Arsava, Atilla Özcan Özdemir, Erdem Gürkaş, Dilek Necioğlu Örken, Şerefnur Öztürk |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-03-01
|
Series: | Türk Nöroloji Dergisi |
Subjects: | |
Online Access: | http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-01212 |
Similar Items
-
Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions
by: Mehmet Akif Topçuoğlu, et al.
Published: (2017-12-01) -
Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series
by: Mustafa Çetiner, et al.
Published: (2020-06-01) -
Successful treatment of pulmonary embolism in a patient with polycythemia vera by rheolytic thrombectomy
by: Tufan Çinar, et al.
Published: (2019-11-01) -
Comparison of Intracranial Hemorrhage and Clinical Outcomes Among Patients Undergoing Mechanical Thrombectomy with and without Thrombolytic Therapy
by: Zulfikar Memis, et al.
Published: (2024-09-01) -
The Effect of Homocysteine Levels on Thrombolytic Treatment in Acute Ischemic Stroke
by: Ezgi Yılmaz, et al.
Published: (2022-12-01)